Pharmaco-epidemiological Description of the Patient Population Treated With Aptivus Under Market Conditions, Safety & Efficacy
Phase of Trial: Phase IV
Latest Information Update: 02 Oct 2014
At a glance
- Drugs Tipranavir (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 07 Jun 2017 Biomarkers information updated
- 05 Jun 2009 Actual patient number (42) added as reported by ClinicalTrials.gov.
- 05 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.